Suspicions Persist Over Vytorin's Cancer Risk
Lawmakers' doubts about the integrity of a Vytorin study they requested from manufacturers Merck & Co. and Schering-Plough Corp. and concerns that the drug causes cancer have not been abated after...To view the full article, register now.
Already a subscriber? Click here to view full article